[eGongsi Notice] KOSDAQ -11th

by Gi Yeonjin

Published 12 Nov.2021 07:57(KST)

[Asia Economy Reporter Ji Yeon-jin]

◆ Telechips = Q3 sales KRW 36.5 billion (+59.7%), operating profit KRW 2.1 billion (turned profitable), net profit KRW 2.8 billion (turned profitable)

◆ YG Entertainment = Q3 sales KRW 85.9 billion (+31.2%), operating profit KRW 17.3 billion (+370.7%), net profit KRW 0.5 billion (-64.3%)

◆ Seegene = Q3 sales KRW 305.3 billion (-6.6%), operating profit KRW 128.6 billion (-38.7%), net profit KRW 93.2 billion (-38.9%), cash dividend of KRW 200 per share decided.

◆ Mecaro = New facility investment for development and commercialization of ceramic heater blocks and ESC worth KRW 10 billion.

◆ DK&D = Decided a bonus issue of 1 new share per 1 existing share.

◆ Humax = Q3 sales KRW 157.3 billion (-27.5%), operating loss KRW 7 billion (-146.7%), net loss KRW 4.4 billion (+70.1%)

◆ NHN Korea Cyber Payment = Decided a bonus issue of 0.5 new shares per 1 existing share.

◆ Osstem Implant = Decided a paid-in capital increase worth KRW 20 billion for debt repayment and others.

◆ Pharma Research = The Ministry of Food and Drug Safety (MFDS) of Seoul issued a provisional manufacturing suspension order for Rientox 100 units per week of subsidiary Pharma Research Bio.

◆ Hyundai Bio = MFDS approved phase 1 clinical trial plan for COVID-19 treatment.

◆ Hugel = Seoul Administrative Court suspended the effect of MFDS’s provisional manufacturing and sales suspension order on Botulax product until November 26.